Design to Dose: Integrating Quantitative Insights Across the Antibody Drug Conjugate ( <scp>ADC</scp> ) Development Lifecycle

Daniel Bending, Eshita Khera, Inez Lam, Innocent G. Asiimwe, Venkatesh Pilla Reddy

Open source

DOI
10.1111/cts.70768
Published
2026-11
Container
Clinical and Translational Science
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.70768,
  title = {Design to Dose: Integrating Quantitative Insights Across the Antibody Drug Conjugate (
                    <scp>ADC</scp>
                    ) Development Lifecycle},
  author = {Daniel Bending and Eshita Khera and Inez Lam and Innocent G. Asiimwe and Venkatesh Pilla Reddy},
  year = {2026},
  journal = {Clinical and Translational Science},
  doi = {10.1111/cts.70768},
  url = {https://doi.org/10.1111/cts.70768}
}

RIS

TY  - JOUR
TI  - Design to Dose: Integrating Quantitative Insights Across the Antibody Drug Conjugate (
                    <scp>ADC</scp>
                    ) Development Lifecycle
AU  - Daniel Bending
AU  - Eshita Khera
AU  - Inez Lam
AU  - Innocent G. Asiimwe
AU  - Venkatesh Pilla Reddy
PY  - 2026
JO  - Clinical and Translational Science
DO  - 10.1111/cts.70768
UR  - https://doi.org/10.1111/cts.70768
ER  - 

APA

Bending, D., Khera, E., Lam, I., Asiimwe, I. G., & Reddy, V. P. (2026). Design to Dose: Integrating Quantitative Insights Across the Antibody Drug Conjugate ( <scp>ADC</scp> ) Development Lifecycle. Clinical and Translational Science. https://doi.org/10.1111/cts.70768

Source records